Ardelyx Cash Flow Statement
NASDAQ: ARDXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.28+0.01 (+0.31%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ardelyx free cash flow
In fiscal 2025, Ardelyx generated -$42.5 million of operating cash flow and spent $1.5 million on capital expenditures. That left free cash flow of -$44.0 million, a free-cash-flow margin of -10.8% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Ardelyx cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -61.60M | -39.14M | -66.07M | -67.21M | -158.16M | -94.31M | -94.94M | -91.30M | -64.34M | -112.39M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 3.06M | 2.06M | 1.29M | 1.14M | 2.81M | 2.54M | 2.50M | 2.70M | 2.60M | 1.30M |
| Stock-Based Compensation | 48.96M | 37.38M | 13.53M | 10.75M | 12.04M | 10.58M | 9.94M | 9.23M | 9.59M | 5.32M |
| Change in Working Capital | -35.59M | -53.71M | -34.91M | -14.05M | 587.00K | -2.58M | -1.10M | 9.86M | -13.73M | 11.99M |
| Operating Cash Flow | -42.48M | -44.81M | -89.72M | -70.04M | -152.55M | -81.44M | -76.48M | -70.27M | -65.19M | -92.53M |
| Capital Expenditures | -1.49M | -1.01M | -344.00K | -55.00K | -1.87M | -324.00K | -325.00K | -311.00K | -2.35M | -4.87M |
| Investing Cash Flow | -8.96M | -18.32M | -131.25M | 18.41M | 50.95M | -31.44M | 23.37M | -29.89M | 65.29M | -131.08M |
| Debt Issued | — | — | — | — | — | — | — | 49.29M | — | — |
| Debt Repaid | — | — | — | — | — | -125.00K | — | — | — | — |
| Financing Cash Flow | 54.51M | 106.59M | 146.29M | 75.34M | 83.00M | 22.78M | 155.48M | 103.55M | 685.00K | 191.20M |
| Net Change in Cash | 3.07M | 43.46M | -74.67M | 23.71M | -18.60M | -90.10M | 102.36M | 3.38M | 785.00K | -32.41M |
| Free Cash Flow | -43.98M | -45.82M | -90.06M | -70.10M | -154.42M | -81.76M | -76.81M | -70.58M | -67.55M | -97.40M |
This table shows 10 annual periods of Ardelyx's cash flow statement, from FY 2025 back to FY 2016, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow ARDX's reporting calendar. What is a cash flow statement?